Healthpeak Properties joins Russell 2500 and Russell 2500 Value

Healthpeak Properties (DOC) was recently added to both the Russell 2500 Index and the Russell 2500 Value Benchmark, a move that may influence how index-tracking funds and institutional investors view the stock.

This index inclusion focuses attention on Healthpeak Properties as a healthcare focused real estate investment trust with a US$15.4b market capitalization. It may prompt some investors to reassess how the stock fits into diversified real estate or income oriented portfolios.

Healthpeak Properties has seen firm share price momentum in recent months, with a 30.44% 3 month share price return and 34.38% year to date share price return, while the 5 year total shareholder return of 17.80% is still down overall.

If this kind of index related move has you thinking about where else capital could work, it may be worth scanning for other healthcare and real estate adjacent ideas using our screener for 40 healthcare AI stocks

For Healthpeak Properties, the recent index additions and strong short term returns could signal a reassessment of the business, or simply hotter sentiment around healthcare real estate. So how does the current valuation actually stack up?

Most Popular Narrative: 1% Overvalued

On the most followed narrative, Healthpeak Properties has a fair value estimate of $21.44, slightly below the last close at $21.77. This sets up a tight valuation gap that rests on a specific growth story.

The accelerating shift of surgical and specialty care from inpatient hospital settings to outpatient centers, supported by anticipated regulatory changes (CMS inpatient only default reversal), is set to drive sustained tenant demand and pricing power for Healthpeak's modern, high acuity outpatient medical buildings, which should translate into increased occupancy rates and same store NOI growth.

Curious what kind of revenue expansion and margin path justify paying up for a healthcare REIT like Healthpeak Properties, and why the implied future earnings multiple looks more like a high growth stock than a traditional income vehicle.

Result: Fair Value of $21.44 (OVERVALUED)

However, the Healthpeak Properties story can shift quickly if capital markets stay tight or if small biotech tenants struggle, which could hurt occupancy and rents.

Another Take on Healthpeak Properties Valuation

That 1% gap between Healthpeak Properties' fair value estimate of $21.44 and the $21.77 last close is one way to look at things, but our DCF model points in a very different direction, with an estimated future cash flow value of $38.01 that suggests the stock is trading well below that level.

DCF models are sensitive to assumptions about growth, margins, and discount rates, so the contrast between a tight analyst target and a much higher SWS DCF output raises a simple question for you: which set of assumptions feels more realistic for Healthpeak Properties over the long run?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Healthpeak Properties for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 44 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With Healthpeak Properties, the signals are mixed enough to keep opinions split. Move quickly, review the data, and weigh the 1 key reward and 4 important warning signs.

Looking for more investment ideas beyond Healthpeak Properties?

If Healthpeak Properties has sharpened your focus, do not stop here. Use the Simply Wall Street screener to uncover fresh stocks that could fit your goals.

• Spot opportunities that appear priced below their fundamentals by reviewing the carefully filtered list of 44 high quality undervalued stocks.
• Strengthen your income stream by assessing companies in the 9 dividend fortresses that may offer higher yields with robust payout histories.
• Prioritize resilience by scanning stocks in the 72 resilient stocks with low risk scores that score well on financial stability and downside risk.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.